Project Grant K23DA065050
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $181K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Lebanon, NH 03756, USA
Similar Awards
- The National Institute on Drug Abuse awarded Hennepin Healthcare Research Institute $193,320 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support development of a mentored career development award (K01) focused on improving behavioral healthcare for mothers with opioid use disorder, their children, and families. The award funds a five-year research initiative through June 30, 2031, based in Minneapolis, Minnesota. The investigator will develop a strategy...
- The National Institute on Drug Abuse awarded Trustees of Boston University $193,751 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a career development research initiative examining quality of care in outpatient substance use disorder treatment facilities. The award funds a five-year training and research plan designed to develop the principal investigator as an independent substance use disorder services researcher. The research uses a novel...
- The National Institute on Drug Abuse awarded the University of California, Los Angeles $169,776 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year research and career development project. Dr. Annette Dekker, an emergency physician and health services researcher, will lead a study evaluating how California's CA BRIDGE Initiative—a policy intervention enabling emergency departments to initiate buprenorphine treatment for opioid use...
- The National Institute on Drug Abuse awarded Merrimack College $172,158 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support career development and research training in exercise intervention design for smoking cessation among people with HIV. The award funds a five-year K01 career development grant focused on designing and disseminating theory-based, optimized exercise interventions for tobacco dependence and nicotine cessation. The recipient will...
- The National Institute on Drug Abuse awarded Massachusetts General Hospital $197,640 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year project examining the clinical impact and cost-effectiveness of integrating infectious disease care into rapid-access substance use bridge clinics. The research addresses the syndemic of substance use disorder and infections among people who inject drugs, who face elevated risk of overdose, acute bacterial...
- The National Institute on Drug Abuse awarded Massachusetts General Hospital $435,502 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to establish a quality measurement framework for youth opioid use disorder treatment. The award supports a K24 Midcareer Investigator Award in Patient-Oriented Research led by Dr. Scott Hadland. The research program identifies candidate quality measures through semi-structured interviews with youth, family members, and clinicians;...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $197,624 under the Drug Use and Addiction Research Programs (CFDA 93.279) on April 15, 2026, to support a K01 career development award investigating social network dynamics that influence medication for opioid use disorder (MOUD) engagement among parents who misuse opioids and have dependent children. Dr. Lauren Dayton will conduct an exploratory sequential mixed-methods study guided by the implementation mapping framework...
- The National Institute on Drug Abuse awarded the University of Rochester $156,555 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a K01 postdoctoral research career development project investigating dopaminergic system dysfunction in neurodevelopmental disorders. The award funds a five-year training program (May 1, 2026 through April 30, 2031) in which the principal investigator will conduct independent research on mesocortical dopaminergic...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $197,320 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a K24 Midcareer Investigator Award in Patient-Oriented Research. The award provides protected time for Dr. Oluwaseun Falade-Nwulia, Associate Professor of Infectious Diseases at Johns Hopkins University, to expand a structured mentoring program for trainees and early-stage investigators focused on improving health...
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...